News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
564,800 Results
Type
Article (41015)
Company Profile (82)
Press Release (523695)
Multimedia
Podcasts (71)
Webinars (15)
Section
Business (152259)
Career Advice (2449)
Deals (27814)
Drug Delivery (110)
Drug Development (73178)
Employer Resources (141)
FDA (13852)
Job Trends (12265)
News (272202)
Policy (27129)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2547)
Academic (1)
Accelerated approval (33)
Adcomms (29)
Allergies (134)
Alliances (38471)
ALS (171)
Alzheimer's disease (1674)
Antibody-drug conjugate (ADC) (305)
Approvals (14084)
Artificial intelligence (476)
Autoimmune disease (143)
Automation (36)
Bankruptcy (310)
Best Places to Work (9996)
BIOSECURE Act (16)
Biosimilars (171)
Biotechnology (61)
Bladder cancer (153)
Brain cancer (56)
Breast cancer (608)
Cancer (4604)
Cardiovascular disease (400)
Career advice (2074)
Career pathing (36)
CAR-T (260)
CDC (45)
Cell therapy (694)
Cervical cancer (28)
Clinical research (62923)
Collaboration (1464)
Company closure (4)
Compensation (609)
Complete response letters (63)
COVID-19 (2580)
CRISPR (85)
C-suite (885)
Cystic fibrosis (123)
Data (6004)
Decentralized trials (2)
Denatured (10)
Depression (143)
Diabetes (481)
Diagnostics (6028)
Digital health (38)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (221)
Drug pricing (171)
Drug shortages (25)
Duchenne muscular dystrophy (229)
Earnings (57850)
Editorial (55)
Employer branding (18)
Employer resources (133)
Events (78406)
Executive appointments (987)
FDA (16756)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (21)
Funding (1279)
Gene editing (182)
Generative AI (42)
Gene therapy (591)
GLP-1 (944)
Government (4363)
Grass and pollen (7)
Guidances (379)
Healthcare (16042)
HIV (60)
Huntington's disease (46)
IgA nephropathy (83)
Immunology and inflammation (266)
Immuno-oncology (55)
Indications (105)
Infectious disease (2847)
Inflammatory bowel disease (182)
Inflation Reduction Act (13)
Influenza (112)
Intellectual property (236)
Interviews (526)
IPO (12621)
IRA (49)
Job creations (2585)
Job search strategy (1674)
JPM (55)
Kidney cancer (18)
Labor market (60)
Layoffs (505)
Leadership (38)
Legal (5777)
Liver cancer (90)
Longevity (10)
Lung cancer (654)
Lymphoma (363)
Machine learning (34)
Management (51)
Manufacturing (675)
MASH (178)
Medical device (10903)
Medtech (10948)
Mergers & acquisitions (16152)
Metabolic disorders (1238)
Multiple sclerosis (158)
NASH (23)
Neurodegenerative disease (321)
Neuropsychiatric disorders (93)
Neuroscience (2899)
Neurotech (1)
NextGen: Class of 2026 (5536)
Non-profit (4011)
Now hiring (55)
Obesity (567)
Opinion (269)
Ovarian cancer (161)
Pain (192)
Pancreatic cancer (220)
Parkinson's disease (270)
Partnered (28)
Patents (473)
Patient recruitment (476)
Peanut (49)
People (52394)
Pharmaceutical (19)
Pharmacy benefit managers (18)
Phase 1 (19364)
Phase 2 (27642)
Phase 3 (21119)
Pipeline (5117)
Policy (271)
Postmarket research (2313)
Preclinical (7901)
Press Release (54)
Prostate cancer (230)
Psychedelics (55)
Radiopharmaceuticals (254)
Rare diseases (827)
Real estate (4133)
Recruiting (60)
Regulatory (21183)
Reports (31)
Research institute (2169)
Resumes & cover letters (358)
Rett syndrome (26)
RNA editing (15)
RSV (70)
Schizophrenia (151)
Series A (211)
Series B (165)
Service/supplier (3)
Sickle cell disease (96)
Special edition (18)
Spinal muscular atrophy (155)
Sponsored (38)
Startups (2771)
State (2)
Stomach cancer (18)
Supply chain (90)
Tariffs (72)
The Weekly (60)
Vaccines (942)
Venture capital (82)
Weight loss (376)
Women's health (72)
Worklife (19)
Date
Today (117)
Last 7 days (492)
Last 30 days (1949)
Last 365 days (26285)
2026 (3257)
2025 (26509)
2024 (30562)
2023 (34109)
2022 (44533)
2021 (47775)
2020 (46289)
2019 (39636)
2018 (30038)
2017 (26954)
2016 (25621)
2015 (29993)
2014 (22453)
2013 (18242)
2012 (19474)
2011 (20495)
2010 (18091)
Location
Africa (732)
Alabama (75)
Alaska (4)
Arizona (208)
Arkansas (11)
Asia (34901)
Australia (7259)
California (9324)
Canada (2986)
China (1024)
Colorado (397)
Connecticut (383)
Delaware (312)
Europe (78301)
Florida (1516)
Georgia (299)
Hawaii (1)
Idaho (52)
Illinois (761)
India (61)
Indiana (452)
Iowa (17)
Japan (402)
Kansas (112)
Kentucky (29)
Louisiana (24)
Maine (57)
Maryland (1219)
Massachusetts (6496)
Michigan (284)
Minnesota (479)
Mississippi (4)
Missouri (121)
Montana (25)
Nebraska (24)
Nevada (108)
New Hampshire (73)
New Jersey (2707)
New Mexico (21)
New York (2553)
North Carolina (1190)
North Dakota (6)
Northern California (4488)
Ohio (272)
Oklahoma (10)
Oregon (30)
Pennsylvania (1937)
Puerto Rico (23)
Rhode Island (37)
South America (996)
South Carolina (60)
South Dakota (1)
Southern California (3742)
Tennessee (144)
Texas (1531)
United States (33638)
Utah (308)
Vermont (1)
Virginia (235)
Washington D.C. (65)
Washington State (791)
West Virginia (4)
Wisconsin (90)
Wyoming (2)
564,800 Results for "circulogene formerly known as circulogene theranostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Circulogene Expands Solid Tumor Genomic Capabilities with Launch of OncoGenDx Tissue Assay
October 7, 2025
·
2 min read
Press Releases
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025
·
13 min read
Press Releases
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates
January 28, 2026
·
8 min read
Press Releases
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
December 15, 2025
·
5 min read
Press Releases
Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs
October 21, 2025
·
6 min read
Press Releases
Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases
November 18, 2025
·
4 min read
Press Releases
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204
November 13, 2025
·
3 min read
Press Releases
Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer
November 19, 2025
·
2 min read
Metabolic disorders
Ascendis Skids as FDA Detects Death in Patient Formerly on Yorvipath
The death occurred in a patient who had a complex medical background and who was being managed with several drugs, according to RBC Capital.
October 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
July 30, 2025
·
6 min read
1 of 56,480
Next
